Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double strategy with growth hormone and vaccines to expand T-cell repertoire in HIV-1 infection
2004-001413-34Phase 4Active
- Sponsor
- Bonaventura Clotet Sala
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatotropin in human immunodeficiency virus infection (HIV), sponsored by Bonaventura Clotet Sala. Primary endpoint: Recovery of tetanus and hepatitis A immune-specific responses at week 24. Started Jan 2006; status: active.
02
Drugs
somatotropin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-001413-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001413-34.